top of page

State of Possible: Laurel Biotherapeutics is a startup that is developing antibodies for cardiovascular disease - they are already benefiting from the support that the Boston area offers

  • Mar 26
  • 1 min read

Co-Founders Matthew Therkelsen and Tatiana Blanchard describe the work that Laurel is doing and some of the support they have received as they launch the company, such as help with lab space.



 
 

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page